Approval Letter NOVARTIS (Mar 9, 2026)
FDA posted an approval letter for SANDIMMUNE on 2026-03-09. This is the document posting date; consult the signed letter for the decision date. The source metadata identifies NDA 050573, NDA 050574, NDA 050625 as a supplement. Review the exact FDA letter for the approved conditions and labeling.
